Dr. Niran Al-Agba

Gaming the System: Pediatrics, Mammograms, and MACRA

Imagine what quality metrics the pediatric cardiac surgeon is going to track. He would do well to collect statistics on how often he images patients for appendicitis because it is likely a rare occurrence. Things are really looking up for the use of data and technology in healthcare. Costs are likely to keep rising with everyone scoring in the 99th% percentile once they figure out how to game the system. But we certainly cannot stand in the way of science or progress now can we?

Niran Al-Agba2020-05-14T03:27:54+00:00February 21, 2017|Categories: Policy, Practice|Tags: ACA, Affordable Care, MACRA, MIPS, Physician Autonomy, Transparency, Value-based Care|

Mylan May Have Been “The Shot Heard Round the World”

U.S. Healthcare needs a revolution; ‘the shot heard round the world’ frequently refers to the opening shots of the American Revolution in 1775. The Big Pharma lobby is holding the American people hostage with their exorbitant ransom demands. Last summer, Mylan Pharmaceuticals, led by CEO Heather Bresch, overplayed their hand. Mylan came under fire for a 400% price increase in the EpiPen two-pack. This device is considered life-saving for children and adults with anaphylactic reactions to various food, insect, or environmental insults. Ms. Bresch insisted the significant price increase ($600-$700 for a medication which costs pennies) was justified due to the more ergonomic appearance of the delivery device and improved safety profile.

Niran Al-Agba2020-05-14T03:23:39+00:00January 27, 2017|Categories: Patient, Policy|Tags: Affordable Care, Corporatization, Corruption, Epi Pen, Health Policy, Mylan, Transparency|

Previous 23